A new report reveals the Biden administration’s pressure on federal health agencies to fast-track Covid-19 vaccine mandates, ignoring and sidestepping vaccine safety protocols in the process.
According to the House Administrative State Subcommittee report, the administration bullied FDA officials to “go beyond their legal authorities” and ignore risks revealed in the initial release of the Emergency Use Authorization (EUA) vaccine. The report further states that the administration mandated Covid shots for the military and federal employees, despite the lack of full licensure.
The FDA’s own policy regarding EUA vaccines required monitoring and communication of findings regarding the effects of a product being rolled out under the lower emergency response standard. However, the administration purportedly “pivoted away from this important requirement” and sought to ensure the EUA vaccine received full licensure to support vaccine mandates.
The report reveals that FDA policy was altered to rush the vaccine’s licensing and subsequent recommendations for vaccine boosters. Interviews with FDA officials responsible for vaccine approval showed that the agency “rushed the vaccine licensing” despite evidence showing the EUA vaccine could harm patients.
Documents and interviews from FDA officials further revealed that the Biden administration aimed to fully approve Pfizer’s Covid jab through the Biologics Licensing Application (BLA) process, despite concerns from FDA experts regarding the risks for healthy young people caused by the vaccine, particularly the risk of myocarditis.
According to the report, the decision to sidestep basic safety protocols was attributed to pressure to mandate the vaccine. Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, testified that his decision to rush the shot’s approval was to “appease outsiders who wanted to have an approved vaccine that gave them more confidence” in a vaccine.
The FDA official removed experts who voiced concerns during the BLA process to ensure a quicker approval, despite concerns regarding EUA vaccine injuries.
